AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
Log in

ASX:TTBTotal Brain Stock Price, Forecast & News

A$0.54
0.00 (0.00 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$0.49
Now: A$0.54
A$0.54
50-Day Range N/A
52-Week Range
A$0.19
Now: A$0.54
A$1.20
Volume126,326 shs
Average VolumeN/A
Market Capitalization$58.48 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Total Brain Limited, through its subsidiaries, engages in developing and commercializing brain health products in Australia and the United States. The company's products include Total Brain, a brain health platform for assessing and training new brain habits; iSPOT-D, a personalized medicine research study in depression; and iSPOT-A, a multicenter, international, prospective, and open-label effectiveness trial that aims to identify objective indicators of treatment response in ADHD subjects using cognitive and brain function measures, brain structure, and genetic measures. The company was formerly known as Brain Resource Limited. Total Brain Limited was founded in 2000 and is headquartered in San Francisco, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone415-399-7990

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.69 million
Cash FlowA$0.08 per share
Book ValueA$0.25 per share

Profitability

Miscellaneous

Employees29
Market Cap$58.48 million
Next Earnings DateN/A
OptionableNot Optionable

Receive TTB News and Ratings via Email

Sign-up to receive the latest news and ratings for TTB and its competitors with MarketBeat's FREE daily newsletter.

Total Brain (ASX:TTB) Frequently Asked Questions

Has Total Brain been receiving favorable news coverage?

Media headlines about TTB stock have been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Total Brain earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutTotal Brain.

Who are some of Total Brain's key competitors?

Who are Total Brain's key executives?

Total Brain's management team includes the following people:
  • Dr. Evian Gordon, Founder & Exec. Chairman
  • Mr. Louis Gagnon, MD, CEO & Director
  • Mr. Emil Vasilev, Director of Fin. & Operations
  • Mr. Matthew Mund, Chief Operating Officer
  • Mr. Marcel Legrand, Head of Revenue & Corp. Devel.

What is Total Brain's stock symbol?

Total Brain trades on the ASX under the ticker symbol "TTB."

What is Total Brain's stock price today?

One share of TTB stock can currently be purchased for approximately A$0.54.

How big of a company is Total Brain?

Total Brain has a market capitalization of $58.48 million and generates $3.69 million in revenue each year. Total Brain employs 29 workers across the globe.

What is Total Brain's official website?

The official website for Total Brain is www.totalbrain.com.

How can I contact Total Brain?

The company can be reached via phone at 415-399-7990.

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.